Immunotherapy-May-Help-Patients-with-Advanced-Esophageal-Cancer
Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
NewYork-Presbyterian-Hospital-Expands-Virtual-Care-with-Philips
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that NewYork-Presbyterian Hospital will expand its telehealth capabilities with Philips remote patient monitoring.
Hepatitis-Common-in-New-Cancer-Patients
A multicenter study from SWOG Cancer Research Network found that infections with hepatitis B and C are common in new cancer patients, but few of these patients are screened for these viruses.
NYP-WD-Achieves-Designation-from-ANCC-Magnet-Recognition-Program
NewYork-Presbyterian Westchester Division announced today that it has received national recognition for excellence in nursing from the American Nurses Credentialing Center’s (ANCC) Magnet Recognition Program®, the highest and most prestigious distinction that a health care organization can earn for nursing excellence and innovation.
NYP-Office-of-Comms-Recognized-with-Numerous-Awards-in-2018
NewYork-Presbyterian’s Office of Communications was recognized by numerous communications and marketing organizations for its creative and dynamic campaigns and initiatives in 2018.
Researchers-Study-Radioactive-Drugs-for-Prostate-Cancer-Therapy
Researchers at Weill Cornell Medicine, in collaboration with investigators at Dana-Farber Cancer Institute, have been awarded a three-year, $1 million grant from the U.S. Department of Defense (DoD) for prostate cancer clinical trials.
NYP-Named-One-of-the-Best-Places-to-Work-in-2019-by-Glassdoor
NewYork-Presbyterian Hospital has been recognized by Glassdoor as one of the Best Places to Work in 2019. NewYork-Presbyterian was the top-ranked hospital in New York and ranked third nationally among hospital systems that made the list.
NYP-MSTU-Wins-2018-Champions-and-Visionaries-of-Healthcare-Award
NewYork-Presbyterian Brooklyn Methodist Hospital’s Mobile Stroke Treatment Unit (MSTU) received a 2018 Champions and Visionaries of Healthcare Award at a recent event sponsored by the Brooklyn Daily Eagle and its long-standing parent company, EBrooklyn Media. The honorees were recognized for leading innovative health care practices that make a difference in patients’ lives in Brooklyn.
Page75 of 333